A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to help determine the best treatment for preventing blood clots that are formed following trauma that could potentially lead to death.
The purpose of this study is to create a research registry of patients with NAFL (non alcoholic fatty liver) or NASH (non alcoholic steatohepatitis)in order to assess the safety and effectiveness of current and future therapies. The goal is to identify the factors associated with favorable versus suboptimal clinical response …
What is the purpose of this study?The purpose of having a database is to collect data related to endoscopic procedures performed by Indiana University physicians specifically for the treatment of gastroparesis. This data will be used for research purposes only to determine the clinical impact of endoscopic treatments on gastroparesis. …
The purpose of this study is to collect specimens and data from Pulmonary Hypertension patients at baseline, at months 3,6,12 of treatment, and during a hospitalization for exacerbation of PH.
The purpose of this study is to thoroughly examine kidney stones, kidney tissue, urines, and medical history of patients to help determine causes and/or the most effective treatments, including preventative treatments, of kidney stones.
What is the purpose of this study?The purpose of this study is to participate in a registry of patients with congenital heart disease. Patient data from the United States, Canada, and South America (whose institutions of care are members of the Congenital Heart Surgeon’s Society) will be submitted to this …
The study is to determine how often nonalcoholic fatty liver disease happens among women with PCOS and to understand the risk factors associated with it.
The purpose of this study is to better understand what factors, demographic characteristics, and interventions predict better recovery-related outcomes.
In an unbiased CRISPR screen, RIPK1 was identified as a top gene contributing to immunotherapy resistance. In addition, RIPK1 has been reported to drive pancreatic oncogenesis. In murine models, inhibition of RIPK1 kinase activity in the pancreatic tumor microenvironment leads to the replacement of tumor-permissive myeloid infiltrates with innate cells …